[In vitro drug sensitivity profiling in melanoma].
Ugurel
Selma
S
Klinik für Dermatologie, Venerologie und Allergologie Julius-Maximilians-Universität Würzburg Josef-Schneider-Str. 2, Geb. D8 D-97080 Würzburg. ugurel_s@klinik.uni-wuerzburg.de
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D018450:Disease Progression; D006801:Humans; D066298:In Vitro Techniques; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate; D014410:Tumor Stem Cell Assay
D000970:Antineoplastic Agents; D003606:Dacarbazine